📱Download Our FREE App & Discover the Next Big Investment Opportunities (US & UK only): https://optothemes.onelink.me/BZDG/ti...

In this episode, Jeff Desjardins, Editor-in-Chief of @visualcap, delves into a pivotal theme driving the 'Exponential Age' — genomics. 🧬

"In 10 to 20 years, it's going to be hard to imagine the world without it," says Jeff.

He expertly uncovers the powerful forces driving the genomics revolution, exploring how winds of change are pushing the boundaries of gene editing and CRISPR. As he navigates through the complexities of this transformative field, Jeff sheds light on the latest breakthroughs and advancements that are reshaping the future of gene editing. 🌐

🔥 If you enjoyed this video, PLEASE show your support by hitting the 'SUBSCRIBE' button 👉    / @optothemes  

► Read the full story here: https://optothemes.page.link/yBXw

Check out our podcast and subscribe, so you don't miss an episode:
► Apple Podcasts: https://podcasts.apple.com/gb/podcast...
► Spotify: https://open.spotify.com/show/4okyrCp...

► Want further OPTO insights? Check out our daily newsletter: https://www.cmcmarkets.com/en/opto/ne...

#genomics #CRISPR #sicklecelldisease #fda #exponentialage #innovation #geneediting #genomesequencing #techinnovation

---------
OPTO is owned by CMC Markets. CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment, or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by OPTO or the guest that any particular investment, security, transaction or investment strategy is suitable for any specific person.